在炎症性肠病治疗提奥普林前后感染的风险:基于人口的研究
Johanna Holmgren1,2, Alice Akhlaghi1,2, Isabel Drake1,2
1Department of Gastroenterology, Skåne University Hospital.
Journal of clinical gastroenterology
|February 17, 2026
概括
对于炎症性肠病 (IBD) 的提奥普林治疗增加了轻度感染的风险,特别是病毒性感染. 然而,它并没有显著增加患者中适度至严重感染的发生率.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 提奥普林是对炎症性肠病 (IBD) 的确立治疗方法.
- 在IBD患者中使用 thiopurine 相关的感染风险的现实数据有限.
- 了解感染模式对于优化IBD管理至关重要.
研究的目的:
- 为了确定IBD患者在开始提奥普林治疗之前和之后感染的发生率,类型和严重程度.
- 评估在临床环境中氨酸对感染风险的现实影响.
- 提供数据,以便在IBD.中使用 thiopurine 进行明智的临床决策.
主要方法:
- 在瑞典斯卡内大学医院 (2015-2022) 进行了对未服用硫黄素的IBD成人患者的回顾性队列研究.
- 感染数据从电子健康记录中收集,用于thiopurine开始前后两年的感染数据.
- 分析包括发病率,发病率比率 (IRR) 和置信区间 (CI).
主要成果:
- 任何感染的发病率从每100个人年中的22.4个增加到每100个人年中的31.8个.
- 提奥普林的使用与轻度感染 (IRR=1.8) 和病毒感染 (IRR=2.3) 的风险增加相关.
- 在中度至重度感染中没有发现显著增加 (IRR=1.2).
结论:
- 提奥普林与IBD患者中较高的轻度感染发病率有关,特别是病毒型.
- 适度至严重感染的风险没有显著增加与 thiopurine 使用.
- 虽然在严重感染方面通常是安全的,但轻度感染的负担需要临床关注,以确保患者的坚持和生活质量.
相关概念视频
Factors Affecting the Risk of Infection
13.9K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
563
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
563
Inflammatory Bowel Disease V: Surgical Management
728
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
728
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
936
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
936
Inflammatory Bowel Disease IV: Pharmacological Management
817
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
817
Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K


